Skip to main content
. 2020 Jun 5;74(2):175–182. doi: 10.1016/j.rec.2020.05.018

Table 6.

Association between ACEI/ARB with a composite endpoint of death and heart failure

Event Death + heart failure
(whole cohort)
Death + heart failure
(admitted to hospital)
Univariate analysis
OR 95%CI P OR 95%CI P
 ACEI/ARB 1.85 1.08-3.15 .025 1.35 0.56-3.26 .499
 ACEI/ARB ≥ 1 y 2.21 1.27-3.84 .005 1.27 0.66-2.47 .477
 ACEI 1.63 0.75-3.55 .219 1.16 0.61-2.19 .659
 ACEI ≥ 1 y 1.86 0.81-4.27 .143 1.68 0.65-4.37 .285
 ARB 1.71 0.92-3.18 .089 0.95 0.45-2.02 .902
 ARB ≥ 1 y 2.11 1.11-4.01 .023 1.01 0.46-2.20 .989
Multivariate analysis*
OR 95%CI P OR 95%CI P
 ACEI/ARB 1.06 0.39-2.83 .915 1.07 0.25-4.64 .927
 ACEI/ARB ≥ 1 y 1.57 0.58-4.26 .369 1.03 0.23-4.60 .964
 ACEI 1.15 0.40-3.36 .807 1.18 0.24-5.83 .840
 ACEI ≥ 1 y 1.25 0.39-4.06 .708 0.98 0.17-5.67 .976
 ARB 0.94 0.36-2.47 .895 0.92 0.22-3.89 .912
 ARB ≥ 1 y 1.35 0.51-3.56 .544 1.05 0.24-4.53 .945
Propensity score matching
OR 95%CI P OR 95%CI P
 ACEI/ARB 0.78 0.29-2.08 .618 1.20 0.37-3.89 .764
 ACEI/ARB ≥ 1 y 0.72 0.26-2.02 .528 1.93 0.59-6.24 .279
 ACEI 1.26 0.38-4.13 .704 1.29 0.29-5.77 .743
 ACEI ≥ 1 y 1.34 0.35-5.06 .669 1.17 0.20-6.77 .862
 ARB 0.58 0.18-1.87 .583 0.35 0.27-3.24 .913
 ARB ≥ 1 y 0.51 0.14-1.86 .310 1.94 0.56-6.70 .295

95%CI, 95% confidence interval; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; OR, odds ratio.

*

Whole cohort: adjustment of variables with P < .05 in univariate analysis (fever, arterial oxygen saturation < 95%, age, sex, obesity, health care worker, care dependency, hypertension, diabetes, dyslipidemia, peripheral artery disease, heart disease, atrial fibrillation, lung disease, renal impairment, stroke/ transient ischemic attack). Cohort admitted to hospital: adjustment of variables with P < .05 in multivariate analysis (fever, arterial oxygen saturation < 95%, age, sex, obesity, health care worker, care dependency, hypertension, diabetes, dyslipidemia, peripheral artery disease, heart disease, atrial fibrillation, lung disease, renal impairment, stroke/transient ischemic attack, hemoglobin, leukocytes, lymphocytes, creatinine, elevated troponin levels, D-dimer, ferritin, C-reactive protein, interleukin-6) (table 1 of the supplementary data).